$9,427.7 Million Neuromodulation Devices Markets - Global Forecast To 2029 - ResearchAndMarkets.com
Retrieved on:
Wednesday, April 19, 2023
Medical Devices, Health, Epilepsy, SNS, VNS, Urinary incontinence, Mood disorder, Anxiety, PD, Prevalence, OCD, Obstructive sleep apnea, Central sleep apnea, Hospital, DSM-IV codes, Ageing, Stroke, Incontinence, Spinal cord, OSA, Multiple sclerosis, Parkinson, CNS, Central nervous system, Government, Pain, Pain management, DBS, Incidence, Parkinson's disease, Spinal cord stimulator, Chronic pain, Gastroenterology, Myenteric plexus, Alzheimer's disease, Obsessive–compulsive disorder, Growth, Urology, Eagle syndrome, Cranial nerves, Disease, SCS, Video game, Pharmaceutical industry, Medical device, Speciality chemicals, Gastroparesis, Depression, Dystonia
The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.
- The neuromodulation devices global market is expected to reach $9,427.7 million by 2029 growing at a high single digit CAGR from 2022 to 2029.
- The emergence of neuromodulation as add-on therapy, technological innovations in neuromodulation, expansion in emerging markets and the rise in the number of clinical studies performed provides immense opportunities to the neuromodulation market.
- Based on the product, the neuromodulation global market is segmented into invasive neuromodulation devices and non-invasive neuromodulation devices.